Back to Search Start Over

A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole.

Authors :
Sirek, Greta
Ulysse, Sciaska
Jacques Toussaint, Marie
Nosamiefan, Chisa
Desrosiers, Ludwige
Chandler, Mia
Ramsey-Goldman, Rosalind
Fleurissaint, Dieufort J.
Feldman, Candace H.
Source :
Vaccine. Apr2024, Vol. 42 Issue 9, p2127-2134. 8p.
Publication Year :
2024

Abstract

• The Vaccine Hesitancy Scale (VHS) survey was translated into Haitian Creole. • Community-engaged method applied to "WHO Guidelines on Translation of Instruments" • Community expertise ensured a culturally and linguistically acceptable translation. • Haitian Creole translated VHS will be used in a future community-engaged study. Accurately translated health materials are needed to achieve equity in vaccine uptake among U.S. individuals with non-English language preferences. Verbatim translations may not capture the cultural and linguistic vernacular required to understand vaccine hesitancy. We leveraged a community-engaged approach to translate the Vaccine Hesitancy Scale (VHS) into Haitian Creole. Following the "WHO Guidelines on Translation and Adaptation of Instruments" and a community-engaged framework, a validated 10-question Vaccine Hesitancy Scale (VHS) underwent forward translation, expert panel review, back translation, and focus group pilot testing. Haitian Creole-speaking translators included two community leaders, one community partner, one study team member, and 13 Haitian, greater Boston-based community members who participated in a focus group to pretest the survey. After four iterations, a linguistic and cultural translation of the VHS was created. A community-engaged framework strengthened community partnerships and resulted in a culturally relevant Haitian Creole vaccine hesitancy scale. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0264410X
Volume :
42
Issue :
9
Database :
Academic Search Index
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
176433804
Full Text :
https://doi.org/10.1016/j.vaccine.2024.02.079